-
Novasep Group
- President, Biopharma Business Unit
2013 - maintenant
NOVASEP
Novasep Group
39, rue Saint-Jean-de-Dieu
F-69007 Lyon, France
President, Biopharma Business Unit
* General Management of the Biopharma Business Unit (280 employees), annual turnover 60 M EUR ;
* Board member of the Executive Committee of Novasep ;
-
NOVASEP
- Chief Executive Officer
POMPEY
2012 - 2012
Novasep Belgium
Avenue des Professeurs Jeener et Brachet
B-6081 Gosselies, Belgique
Chief Executive Officer
* General Management of Contract Manufacturing Organization (100 employees), specialized in the production of viral vectors and recombinant proteins for therapeutic use. ;
* Board member of Novasep Process Division ;
-
Microbial Technologies
- Director
2011 - 2012
MERCK SERONO
MerckSerono BioDevelopment
1, Rue Nicolas Brémontier
F-33650 Martillac, France
Director, Microbial Technologies
* Management of an investment project into a new GMP manufacturing facility for microbial-based products (14.1 mio EUR investment) ;
* Responsible for process technical transfers from CMOs ;
-
EMD Serono Biotech Center
- Site Director
2009 - 2011
EMD SERONO
EMD Serono Biotech Center
Middlesex Turnpike 45A
Billerica, MA01821 - USA
Site Director
* General management of EMD Serono Biotech Center (57 persons), part of the Technical Operations division of MerckSerono.
* Responsible for the supply of preclinical and clinical GMP materials, up to Phase 2 ;
-
Merck Serono Biotech Center
- Associate Director & Deputy Director of the Biotech Process Development Department
2006 - 2009
MERCK SERONO
Merck Serono Biotech Center
Zone Industrielle B
CH-1809 Fenil s/Corsier - Switzerland
Associate Director
* Deputy Director of the Biotech Process Development Department (62 persons). Responsible of process development activities, covering upstream, downstream and analytical activities. Development of production processes for recombinant proteins, expressed in mammalian cell culture. ;
-
Laboratoires SERONO S.A.
- Downstream Group Manager
2003 - 2006
Serono Biotech Center
Zone Industrielle B
CH-1809 Fenil s/Corsier - Switzerland
Downstream Group Manager
* Head of the downstream development group (20 persons): activities covering purification development of recombinant proteins, process scale-up and validation, improvement and troubleshooting of manufacturing processes.
* Project management: leading the Phase 2/3 process development of recombinant proteins. ;
-
EUROGENTEC s.a.
- GMP Production Director
1999 - 2003
Eurogentec is a CRO/CMO working as subcontractor for pharmaceutical industries and providing development and production capacities of recombinant proteins and DNA. Clinical batches of recombinant proteins are regularly produced for phase 1 and 2 clinical trials.
* Management of the pharmaceutical production units (fermentation, purification, QC, maintenance and logistics teams - 30 people).
* Project management from the development phase (R&D) of processes to their transfer to the GMP production unit (production of recombinant proteins and DNA). ;
-
PHAROS s.a.
- R&D Downstream Manager
1996 - 1999
* In charge of the development and the scaling-up of purification methods for a recombinant protein. This work was realized in the scope of the exclusive sub-contracting agreement between SmithKline Beecham Biologicals and Pharos. ;
-
PHAROS s.a.
- Research scientist
1989 - 1996
* Laboratory of biochemistry : HPLC, protein purifications, immunoassay (RIA, RRA, ELISA), electrophoresis, micro and ultrafiltration. ;
* Writing of standard operating procedures (SOP), analytical method validation, quality control of a recombinant protein. Set-up of Good Laboratory Practices (GLP) in the laboratory.
* Work in a pharmaceutical Production Unit, following the Good Manufacturing Practices (GMP) ;
-
UNIVERSITY OF LIEGE
- Assistant
1984 - 1989
